Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

Robert J. Desnick, PhD, MD

Dean for Genetics and Genomic Medicine Emeritus
Professor and Chair Emeritus
Department of Genetics & Genomic Sciences
Mount Sinai School of Medicine
New York, New York, United States

Disclosures

Robert J. Desnick, PhD, MD, has no relevant financial relationships.

Derralynn Hughes, MD

Lysosomal Storage Disorders Unit
Department of Haematology
University College London
Royal Free London NHS Foundation Trust
London, United Kingdom

Disclosures

Derralynn Hughes, MD, has the following relevant financial relationships:
Consultant or advisor for: Amicus; Cheisi; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda
Speaker or member of speakers bureau for: Amicus; Cheisi; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda
Research funding from: Amicus; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda

Alberto Ortiz, MD, PhD

Nephrology and Hypertension Department
IIS-Fundacion Jimenez Diaz
School of Medicine, UAM
Madrid, Spain

Disclosures

Alberto Ortiz, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Amicus; Astellas; AstraZeneca; Bayer; Chiesi; Freeline; Fresenius Medical Care; GlaxoSmithKline; Idorsia; Mundipharma; Otsuka; Sanofi-Genzyme; Sysmex; Vifor Fresenius Medical Care Renal Pharma
Speaker or member of speakers bureau for: Advicciene; Alexion; Amicus; Amgen; Astellas; AstraZeneca; Bayer; Fresenius Medical Care; Kyowa Kirin; Menarini; Mundipharma; Novo-Nordisk; Otsuka; Sanofi-Genzyme; Vifor Fresenius Medical Care Renal Pharma
Research funding from: AstraZeneca; Mundipharma; Sanofi

Michael Beck, MD

SphinCS GmbH
Hochheim
Germany

Disclosures

Michael Beck, MD, has the following relevant financial relationships:
Consultant or advisor for: Shire/Takeda
Speaker or member of speakers bureau for: Shire/Takeda

Editor

Grace O’Malley, PhD

Associate Medical Education Director, WebMD Global, LLC

Disclosures

Grace O’Malley, PhD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

Recognizing Fabry Disease: What Every Clinician Should Know

Authors: Robert J. Desnick, PhD, MD; Derralynn Hughes, MD; Alberto Ortiz, MD, PhD; Michael Beck, MD
CME Released: 11/28/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 11/28/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US Cardiologists, nephrologists, and neurologists practicing across the globe outside the United States.

The goal of this activity is for learners to be better able to provide need-to-know information about Fabry disease that will help to curb the long diagnostic odyssey.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Clinical manifestations of Fabry disease
- Long-term consequences of untreated Fabry disease
- Available disease-modifying treatments
Have greater competence related to
- Confirming a diagnosis of Fabry disease

Disclosures

Disclosures for additional planners can be found here.

Faculty

Robert J. Desnick, PhD, MD

Dean for Genetics and Genomic Medicine Emeritus
Professor and Chair Emeritus
Department of Genetics & Genomic Sciences
Mount Sinai School of Medicine
New York, New York, United States

Disclosures

Robert J. Desnick, PhD, MD, has no relevant financial relationships.

Derralynn Hughes, MD

Lysosomal Storage Disorders Unit
Department of Haematology
University College London
Royal Free London NHS Foundation Trust
London, United Kingdom

Disclosures

Derralynn Hughes, MD, has the following relevant financial relationships:
Consultant or advisor for: Amicus; Cheisi; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda
Speaker or member of speakers bureau for: Amicus; Cheisi; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda
Research funding from: Amicus; Freeline; Idorsia; Protalix; Sanofi; Sangamo; Takeda

Alberto Ortiz, MD, PhD

Nephrology and Hypertension Department
IIS-Fundacion Jimenez Diaz
School of Medicine, UAM
Madrid, Spain

Disclosures

Alberto Ortiz, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Amicus; Astellas; AstraZeneca; Bayer; Chiesi; Freeline; Fresenius Medical Care; GlaxoSmithKline; Idorsia; Mundipharma; Otsuka; Sanofi-Genzyme; Sysmex; Vifor Fresenius Medical Care Renal Pharma
Speaker or member of speakers bureau for: Advicciene; Alexion; Amicus; Amgen; Astellas; AstraZeneca; Bayer; Fresenius Medical Care; Kyowa Kirin; Menarini; Mundipharma; Novo-Nordisk; Otsuka; Sanofi-Genzyme; Vifor Fresenius Medical Care Renal Pharma
Research funding from: AstraZeneca; Mundipharma; Sanofi

Michael Beck, MD

SphinCS GmbH
Hochheim
Germany

Disclosures

Michael Beck, MD, has the following relevant financial relationships:
Consultant or advisor for: Shire/Takeda
Speaker or member of speakers bureau for: Shire/Takeda

Editor

Grace O’Malley, PhD

Associate Medical Education Director, WebMD Global, LLC

Disclosures

Grace O’Malley, PhD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education

CME

Recognizing Fabry Disease: What Every Clinician Should Know

Authors: Robert J. Desnick, PhD, MD; Derralynn Hughes, MD; Alberto Ortiz, MD, PhD; Michael Beck, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 11/28/2022

Valid for credit through: 11/28/2023, 11:59 PM EST

processing....

Select Any Chapter to Begin

Page 1 of 25

Pathophysiology of Fabry Disease - Pre-Assessment

CME Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of WebMD Global, LLC or companies that support educational programming on medscape.org. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Faculty

Robert J. Desnick, PhD, MD

Derralynn Hughes, MD

Alberto Ortiz, MD, PhD

Michael Beck, MD

Editor

Grace O’Malley, PhD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

CME

Recognizing Fabry Disease: What Every Clinician Should Know

Target Audience and Goal Statement

Disclosures

Faculty

Robert J. Desnick, PhD, MD

Derralynn Hughes, MD

Alberto Ortiz, MD, PhD

Michael Beck, MD

Editor

Grace O’Malley, PhD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Recognizing Fabry Disease: What Every Clinician Should Know

Select Any Chapter to Begin